Download Patient Cases - Athenahealth

ONC Health IT
Transparency Disclosures
I.
Disclaimer
This Complete EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the
applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does
not represent an endorsement by the U.S. Department of Health and Human Services.
II.
Certified EHR Vendor & Product Information
Vendor/Development
Name:
Certified EHR Name:
Practice Type:
Previous Certified
Version Numbers (CHPL
Certification ID):
Latest Version No:
CHPL Certification ID:
Latest Certification
Date:
Certification Criteria:
athenahealth, Inc.
athenaClinicals
Ambulatory
14.4 (Cert ID: 140056R00)
14.6 (Cert ID: 140056R02)
14.8 (Cert ID: 140056R04)
14.10 (Cert ID: 140056R06)
14.12 (Cert ID: 140056R08)
15.2 (Cert ID: 150027R00)
15.4 (Cert ID: 150027R02)
15.6 (Cert ID: 150027R04)
15.8 (Cert ID: 150027R06)
15.10 (Cert ID: 150027R08)
15.12 (Cert ID: 150027R10)
16.2 (Cert ID: 150027R12)
16.4 (Cert ID: 150027R14)
16.6 (Cert ID: 150027R16)
16.8 (Cert ID: 150027R18)
16.10 (Cert ID: 150027R20)
16.12 (Cert ID: 150027R22)
17.3
150027R23
March 2017
14.5 (Cert ID: 140056R01)
14.7 (Cert ID: 140056R03)
14.9 (Cert ID: 140056R05)
14.11 (Cert ID: 140056R07)
15.1 (Cert ID: 140056R09)
15.3 (Cert ID: 150027R01)
15.5 (Cert ID: 150027R03)
15.7 (Cert ID: 150027R05)
15.9 (Cert ID: 150027R07)
15.11 (Cert ID: 150027R09)
16.1 (Cert ID: 150027R11)
16.3 (Cert ID: 150027R13)
16.5 (Cert ID: 150027R15)
16.7 (Cert ID: 150027R17)
16.9 (Cert ID: 150027R19)
16.11 (Cert ID: 150027R21)
The following criteria are certified in all versions listed above unless otherwise
specified below:
Complete Ambulatory EHR Certification
1.
2.
3.
4.
5.
6.
170.314(a)(1)
170.314(a)(2)
170.314(a)(3)
170.314(a)(4)
170.314(a)(5)
170.314(a)(6)
COMPUTERIZED PROVIDER ORDER ENTRY
DRUG-DRUG, DRUG-ALLERGY INTERACTION CHECKS
DEMOGRAPHICS
VITAL SIGNS, BODY MASS INDEX, AND GROWTH CHARTS
PROBLEM LIST
MEDICATION LIST
© 2016 athenahealth, Inc.
For athenahealth clients only, do not copy or distribute.
athenahealth.com
Meaningful Use with athenaClinicals
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
170.314(a)(7) MEDICATION ALLERGY LIST
170.314(a)(8) CLINICAL DECISION SUPPORT
170.314(a)(9) ELECTRONIC NOTES
170.314(a)(10) DRUG-FORMULARY CHECKS
170.314(a)(11) SMOKING STATUS
170.314(a)(12) IMAGE RESULTS
170.314(a)(13) FAMILY HEALTH HISTORY
170.314(a)(14) PATIENT LIST CREATION
170.314(a)(15) PATIENT-SPECIFIC EDUCATION RESOURCES
170.314(b)(1) TRANSITIONS OF CARE - RECEIVE, DISPLAY, AND
INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES
170.314(b)(2) TRANSITIONS OF CARE - CREATE AND TRANSMIT TRANSITION
OF CARE/REFERRAL SUMMARIES
170.314(b)(3) ELECTRONIC PRESCRIBING
170.314(b)(4) CLINICAL INFORMATION RECONCILIATION
170.314(b)(5)(A) INCORPORATE LABORATORY TESTS AND VALUES/RESULTS
170.314(b)(5)(B) INCORPORATE LABORATORY TESTS AND
VALUES/RESULTS*
170.314(b)(7) DATA PORTABILITY
170.314(c)(1) CLINICAL QUALITY MEASURES - CAPTURE AND EXPORT
170.314(c)(2) CLINICAL QUALITY MEASURES - IMPORT AND CALCULATE
170.314(c)(3) CLINICAL QUALITY MEASURES - ELECTRONIC SUBMISSION
170.314(d)(1) AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION
170.314(d)(2) AUDITABLE EVENTS AND TAMPER-RESISTANCE
170.314(d)(3) AUDIT REPORT(S)
170.314(d)(4) AMENDMENTS
170.314(d)(5) AUTOMATIC LOG-OFF
170.314(d)(6) EMERGENCY ACCESS
170.314(d)(7) END-USER DEVICE ENCRYPTION
170.314(d)(8) INTEGRITY
170.314(d)(9) ACCOUNTING OF DISCLOSURES (OPTIONAL)
170.314(e)(1) VIEW, DOWNLOAD, AND TRANSMIT TO 3RD PARTY
170.314(e)(2) CLINICAL SUMMARY
170.314(e)(3) SECURE MESSAGING
170.314(f)(1) IMMUNIZATION INFORMATION
170.314(f)(2) TRANSMISSION TO IMMUNIZATION REGISTRIES
170.314(f)(3) TRANSMISSION TO PUBLIC HEALTH AGENCIES - SYNDROMIC
SURVEILLANCE
170.314(f)(5) CANCER CASE INFORMATION
170.314(f)(6) TRANSMISSION TO CANCER REGISTRIES
170.314(g)(2) AUTOMATED MEASURE CALCULATION
170.314(g)(3) SAFETY-ENHANCED DESIGN
170.314(g)(4) QUALITY MANAGEMENT SYSTEM
*170.314(b)(5)(B) certified in versions 16.10 and higher only
Clinical Quality
Measures:
The following clinical quality measures are certified in all versions listed above
unless otherwise specified below:
1. CMS2 PREVENTIVE CARE AND SCREENING: SCREENING FOR CLINICAL
DEPRESSION AND FOLLOW-UP PLAN
2. CMS22 PREVENTIVE CARE AND SCREENING: SCREENING FOR HIGH
BLOOD PRESSURE AND FOLLOW-UP DOCUMENTED
3. CMS50 CLOSING THE REFERRAL LOOP: RECEIPT OF SPECIALIST REPORT**
© 2016 athenahealth, Inc.
Page 2 of 3
Meaningful Use with athenaClinicals
4. CMS52 HIV/AIDS: PNEUMOCYSTIS JIROVECI PNEUMONIA (PCP)
PROPHYLAXIS
5. CMS56 FUNCTIONAL STATUS ASSESSMENT FOR HIP REPLACEMENT
6. CMS61 PREVENTIVE CARE AND SCREENING: CHOLESTEROL – FASTING
LOW DENSITY LIPOPROTEIN (LDL-C) TEST PERFORMED
7. CMS62 HIV/AIDS: MEDICAL VISIT
8. CMS64 PREVENTIVE CARE AND SCREENING: RISK- STRATIFIED
CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C)
9. CMS65 HYPERTENSION: IMPROVEMENT IN BLOOD PRESSURE
10. CMS66 FUNCTIONAL STATUS ASSESSMENT FOR KNEE REPLACEMENT
11. CMS68 DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL
RECORD
12. CMS69 PREVENTIVE CARE AND SCREENING: BODY MASS INDEX (BMI)
SCREENING AND FOLLOW-UP
13. CMS74 PRIMARY CARIES PREVENTION INTERVENTION AS OFFERED BY
PRIMARY CARE PROVIDERS, INCLUDING DENTISTS
14. CMS75 CHILDREN WHO HAVE DENTAL DECAY OR CAVITIES
15. CMS77 HIV/AIDS: RNA CONTROL FOR PATIENTS WITH HIV
16. CMS82 MATERNAL DEPRESSION SCREENING
17. CMS90 FUNCTIONAL STATUS ASSESSMENT FOR COMPLEX CHRONIC
CONDITIONS
18. CMS117 CHILDHOOD IMMUNIZATION STATUS
19. CMS122 DIABETES: HEMOGLOBIN A1C POOR CONTROL
20. CMS123 DIABETES: FOOT EXAM
21. CMS124 CERVICAL CANCER SCREENING
22. CMS125 BREAST CANCER SCREENING
23. CMS126 USE OF APPROPRIATE MEDICATIONS FOR ASTHMA
24. CMS127 PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS
25. CMS128 ANTI-DEPRESSANT MEDICATION MANAGEMENT
26. CMS129 PROSTATE CANCER: AVOIDANCE OF OVERUSE OF BONE SCAN
FOR STAGING LOW RISK PROSTATE CANCER PATIENTS
27. CMS130 COLORECTAL CANCER SCREENING
28. CMS131 DIABETES: EYE EXAM
29. CMS132 CATARACTS: COMPLICATIONS WITHIN 30 DAYS FOLLOWING
CATARACT SURGERY REQUIRING ADDITIONAL SURGICAL PROCEDURES
30. CMS133 CATARACTS: 20/40 OR BETTER VISUAL ACUITY WITHIN 90 DAYS
FOLLOWING CATARACT SURGERY
31. CMS134 DIABETES: URINE PROTEIN SCREENING
32. CMS135 HEART FAILURE (HF): ANGIOTENSIN-CONVERTING ENZYME (ACE)
INHIBITOR OR ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY FOR LEFT
VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
33. CMS136 ADHD: FOLLOW-UP CARE FOR CHILDREN PRESCRIBED
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) MEDICATION
34. CMS137 INITIATION AND ENGAGEMENT OF ALCOHOL AND OTHER DRUG
DEPENDENCE TREATMENT
35. CMS138 PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING
AND CESSATION INTERVENTION
36. CMS139 SCREENING FOR FUTURE FALL RISK
37. CMS140 BREAST CANCER: HORMONAL THERAPY FOR STAGE IC-IIIC
ESTROGEN RECEPTOR/PROGESTERONE RECEPTOR (ER/PR) POSITIVE
BREAST CANCER
38. CMS141 COLON CANCER: CHEMOTHERAPY FOR AJCC STAGE III COLON
CANCER PATIENTS
39. CMS142 DIABETIC RETINOPATHY: COMMUNICATION WITH THE PHYSICIAN
MANAGING ONGOING DIABETES CARE
© 2016 athenahealth, Inc.
Page 3 of 3
Meaningful Use with athenaClinicals
40. CMS143 PRIMARY OPEN ANGLE GLAUCOMA (POAG): OPTIC NERVE
EVALUATION
41. CMS144 HEART FAILURE (HF): BETA-BLOCKER THERAPY FOR LEFT
VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
42. CMS145 CORONARY ARTERY DISEASE (CAD): BETA-BLOCKER THERAPYPRIOR MYOCARDIAL INFARCTION (MI) OR LEFT VENTRICULAR SYSTOLIC
DYSFUNCTION (LVEF <40%)
43. CMS146 APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS
44. CMS147 PREVENTATIVE CARE AND SCREENING: INFLUENZA
IMMUNIZATION
45. CMS148 HEMOGLOBIN A1C TEST FOR PEDIATRIC PATIENTS
46. CMS149 DEMENTIA: COGNITIVE ASSESSMENT
47. CMS153 CHLAMYDIA SCREENING FOR WOMEN
48. CMS154 APPROPRIATE TREATMENT FOR CHILDREN WITH UPPER
RESPIRATORY INFECTION (URI)
49. CMS155 WEIGHT ASSESSMENT AND COUNSELING FOR NUTRITION AND
PHYSICAL ACTIVITY FOR CHILDREN AND ADOLESCENTS
50. CMS156 USE OF HIGH-RISK MEDICATIONS IN THE ELDERLY
51. CMS157 ONCOLOGY: MEDICAL AND RADIATION – PAIN INTENSITY
QUANTIFIED
52. CMS158 PREGNANT WOMEN THAT HAD HBSAG TESTING
53. CMS159 DEPRESSION REMISSION AT TWELVE MONTHS
54. CMS160 DEPRESSION UTILIZATION OF THE PHQ-9 TOOL
55. CMS161 MAJOR DEPRESSIVE DISORDER (MDD): SUICIDE RISK ASSESSMENT
56. CMS163 DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT
57. CMS164 ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR
ANOTHER ANTITHROMBOTIC
58. CMS165 CONTROLLING HIGH BLOOD PRESSURE
59. CMS166 USE OF IMAGING STUDIES FOR LOW BACK PAIN
60. CMS167 DIABETIC RETINOPATHY: DOCUMENTATION OF PRESENCE OR
ABSENCE OF MACULAR EDEMA AND LEVEL OF SEVERITY OF RETINOPATHY
61. CMS169 BIPOLAR DISORDER AND MAJOR DEPRESSION: APPRAISAL FOR
ALCOHOL OR CHEMICAL SUBSTANCE USE
62. CMS177 CHILD AND ADOLESCENT MAJOR DEPRESSIVE DISORDER:
SUICIDE RISK ASSESSMENT
63. CMS179 ADE PREVENTION AND MONITORING: WARFARIN TIME IN
THERAPEUTIC RANGE
64. CMS182 ISCHEMIC VASCULAR DISEASE (IVD): COMPLETE LIPID PANEL AND
LDL CONTROL
**CMS50 certified in versions 14.5 and higher only
Additional Software
Required:
III.
athenaCommunicator, FDB MedKnowledge, Healthwise Patient Instructions,
Surescripts, ntpd, Epocrates
Transparency and Disclosures
(A) Additional types of costs that a user may be required to pay to implement or use the Complete EHR or
Health IT Module’s capabilities, whether to meet meaningful use objectives and measures or to achieve
any other use within the scope of the health IT’s certification:
© 2016 athenahealth, Inc.
Page 4 of 3
Meaningful Use with athenaClinicals
athenahealth's online implementation service is free for practices with one to six physicians. The onsite implementation fee for larger practices and organizations is based on the number of providers
who will be using the athenaClinicals service. All athenaClinicals clients pay a monthly service fee,
which covers all features, functionality, and services required to meet Meaningful Use objectives
and measures. athenahealth’s clients (eligible provider or hospital) would incur no additional costs
either to meet meaningful use objectives and measures or to achieve any other use within the
scope of the Health IT Module’s certification.
athenahealth does not charge additional fees for the development or configuration of interfaces or
health information exchange integration that are required to meet Meaningful Use requirements.
Other health care trading partners and vendors may charge athenahealth clients for the creation,
development, and maintenance of interface or health information exchange integration. Clients
that elect to use services above and beyond requirements to meet Meaningful Use may pay
additional fees.
(B) Limitations that a user may encounter in the course of implementing and using the Complete EHR or
Health IT Module’s capabilities, whether to meet meaningful use objectives and measures or to achieve
any other use within the scope of the health IT’s certification:
athenahealth’s clients (eligible provider or hospital) would incur no limitations either to meet
meaningful use objectives and measures or to achieve any other use within the scope of the Health
IT Module’s certification.
© 2016 athenahealth, Inc.
Page 5 of 3